Publication costs assisted by the National Science FoundationThe reaction of 2,2'-bipyridine (bpy), 1,lO-phenanthroline (phen), and their monoprotonated cations (bpyH+ and phenH+) with radiation-generated one-electron reducing agents yields radicals, the spectra, kinetics, and acid-base properties of which have been established. BpyH2+. has a pK, of 5.6 and exhibits an intense absorption maximum at 375 nm ( e 4.5 X lo4 M-l cm-' 1; bpyH. shows A, , , 365 nm ( E 3.0 X lo4 M-' cm-'). BpyH. decays via second-order kinetics (2h = 4.0 X lo9 M-' sd) representing primarily a disproportionation reaction. BpyH2+. appears to decay via concurrent first-and second-order reactions; the processes are complicated by unidentified dose-dependent sequences. Irrespective of pH, the final isolatable product is a pale yellow solid which can be identified by elemental analysis, molecular weight determination, and IR spectrum as a trimer of dihydrobipyridine isomers. PhenHz+. shows A,, 370 nm (e 7.8 X lo3 M-' cm-l ) and 510 nm ( e 3.8 X lo3 M-l cm-' ) and pK, = 6.3 while phenH. exhibits A, , , 350 nm ( E 5.8 X lo3 M-' cm-' ) and 475 nm (t 3.0 X lo3 M-' cm-l ).PhenH. protonates to form phenHz+-with k = 8.3 X lo9 M-' s-' a nd phenHz+. decays via second-order kinetics (2k = 1.6 x lo9 M-l s-l ). In alkaline solution (pH 10-13) the decay of phenH. is first order ( k = 2 X IO3 9-l).The bimolecular reaction appears to proceed predominantly via combination; a product has been isolated with the empirical formula C12HllN2C104. The behavior of the one-electron reduction products is compared with that of species believed to be similar arising from the photoreduction of bpy and phen in aqueous solution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.